TNFAIP8 regulates gastric cancer growth via mTOR-Akt-ULK1 pathway and autophagy signals

Zheng Chen1, Jianguo Zhang2, Chenyang Dong3

  • 1Tumor Research and Therapy Center, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.

Insights

Tumor necrosis factor-alpha-induced protein 8 (TNFAIP8) is upregulated in gastric cancer (GC). TNFAIP8 promotes GC cell viability and migration while inhibiting apoptosis and activating autophagy via the mTOR-Akt-ULK1 pathway.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Gastric cancer (GC) remains a significant global health challenge.
  • Understanding the molecular mechanisms driving GC progression is crucial for developing effective therapies.

Purpose of the Study:

  • To investigate the role of TNFAIP8 in gastric cancer.
  • To elucidate the molecular pathways influenced by TNFAIP8 in GC cells.

Main Methods:

  • Gene expression analysis (RT-PCR, Western Blot) in GC tissues and cells.
  • In vitro studies involving gene silencing and overexpression in GC cell lines.
  • Functional assays including CCK-8, Transwell, and flow cytometry.
  • In vivo studies using nude mouse xenograft models with histological analysis (HE, IHC).

Main Results:

  • TNFAIP8 mRNA and protein levels were significantly elevated in GC tissues and cells compared to normal controls.
  • Overexpression of TNFAIP8 enhanced GC cell viability, migration, and autophagy.
  • TNFAIP8 overexpression led to decreased apoptosis and inhibition of the mTOR-Akt-ULK1 signaling pathway.
  • Tumor growth was promoted in vivo when TNFAIP8 was overexpressed.

Conclusions:

  • TNFAIP8 plays a critical role in promoting gastric cancer progression.
  • TNFAIP8 appears to exert its effects by down-regulating the mTOR-Akt-ULK1 pathway and activating autophagy.
  • Targeting TNFAIP8 may represent a potential therapeutic strategy for gastric cancer.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.6K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
8.5K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.8K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.3K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.0K